1887
Preview this article:
Zoom in
Zoomout

Investigation of carbapenem heteroresistance among different sequence types of clinical isolates reveals further diversity, Page 1 of 1

| /docserver/preview/fulltext/jmm/60/10/1556_jmm032276-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.032276-0
2011-10-01
2020-01-21
Loading full text...

Full text loading...

/deliver/fulltext/jmm/60/10/1556.html?itemId=/content/journal/jmm/10.1099/jmm.0.032276-0&mimeType=html&fmt=ahah

References

  1. Balaban N. Q., Merrin J., Chait R., Kowalik L., Leibler S.. ( 2004;). Bacterial persistence as a phenotypic switch. . Science 305:, 1622–1625. [CrossRef][PubMed]
    [Google Scholar]
  2. CLSI ( 2008;). Performance Standards for Antimicrobial Susceptibility Testing, 18th Informational Supplement. M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute.
  3. Curran B., Jonas D., Grundmann H., Pitt T., Dowson C. G.. ( 2004;). Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. . J Clin Microbiol 42:, 5644–5649. [CrossRef][PubMed]
    [Google Scholar]
  4. Falagas M. E., Makris G. C., Dimopoulos G., Matthaiou D. K.. ( 2008;). Heteroresistance: a concern of increasing clinical significance?. Clin Microbiol Infect 14:, 101–104. [CrossRef][PubMed]
    [Google Scholar]
  5. Ikonomidis A., Tsakris A., Kantzanou M., Spanakis N., Maniatis A. N., Pournaras S.. ( 2008;). Efflux system overexpression and decreased OprD contribute to the carbapenem heterogeneity in Pseudomonas aeruginosa. . FEMS Microbiol Lett 279:, 36–39. [CrossRef][PubMed]
    [Google Scholar]
  6. Libisch B., Poirel L., Lepsanovic Z., Mirovic V., Balogh B., Pászti J., Hunyadi Z., Dobák A., Füzi M., Nordmann P.. ( 2008;). Identification of PER-1 extended-spectrum beta-lactamase producing Pseudomonas aeruginosa clinical isolates of the international clonal complex CC11 from Hungary and Serbia. . FEMS Immunol Med Microbiol 54:, 330–338. [CrossRef][PubMed]
    [Google Scholar]
  7. Lister P. D., Wolter D. J., Hanson N. D.. ( 2009;). Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. . Clin Microbiol Rev 22:, 582–610. [CrossRef][PubMed]
    [Google Scholar]
  8. Nemec A., Krizova L., Maixnerova M., Musilek M.. ( 2010;). Multidrug-resistant epidemic clones among bloodstream isolates of Pseudomonas aeruginosa in the Czech Republic. . Res Microbiol 161:, 234–242. [CrossRef][PubMed]
    [Google Scholar]
  9. Pournaras S., Ikonomidis A., Markogiannakis A., Spanakis N., Maniatis A. N., Tsakris A.. ( 2007;). Characterization of clinical isolates of Pseudomonas aeruginosa heterogeneously resistant to carbapenems. . J Med Microbiol 56:, 66–70. [CrossRef][PubMed]
    [Google Scholar]
  10. Tenover F. C., Arbeit R. D., Goering R. V., Mickelsen P. A., Murray B. E., Persing D. H., Swaminathan B.. ( 1995;). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. . J Clin Microbiol 33:, 2233–2239.[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.032276-0
Loading
/content/journal/jmm/10.1099/jmm.0.032276-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error